Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-10-04T01:46:05.588Z

DREAM3R

DREAM3R
Mesothelia

DuRvalumab (MEDI4736) with chEmotherapy as first line treAtment in advanced pleural Mesothelioma - A phase 3 Randomised trial

DuRvalumab (MEDI4736) with chEmotherapy as first line treAtment in advanced pleural Mesothelioma - A phase 3 Randomised trial

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Mesothelia

Study Phase

III

Trial Identifiers

NCT04334759


https://www.clinicaltrials.gov/study/NCT04334759

 

GenesisCare Location(s)
Principal Investigator(s)

Prof Nick Pavlakis

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.